Adaptive Biotechnologies Corp

Research Adaptive Biotechnologies Corp (ADPT) on Bullrun: market cap USD 3.42B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerADPT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 3.42B
• Financial periodFY2025
• RevenueUSD 276.98M
• Revenue growth54.8%
• Net income-USD 59.50M
• Free cash flow-USD 48.95M
• Gross margin74.2%

Valuation Snapshot

latest market cap is USD 3.42B.

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system.

Frequently asked questions

What is Adaptive Biotechnologies Corp's market cap?

Adaptive Biotechnologies Corp's market capitalization is USD 3.42B.

What does Adaptive Biotechnologies Corp do?

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.